KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Sales (2016 - 2026)

TherapeuticsMD filings provide 16 years of Return on Sales readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q1 2026 for TherapeuticsMD, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 3.65% in Q2 2022 to a low of 0.45% in Q1 2022.
  • Median Return on Sales over the past 5 years was 0.0% (2025), compared with a mean of 0.14%.
  • Biggest five-year swings in Return on Sales: skyrocketed 367bps in 2022 and later tumbled -365bps in 2023.
  • TherapeuticsMD's Return on Sales stood at 0.0% in 2022, then skyrocketed by 207bps to 0.01% in 2023, then plummeted by -84bps to 0.0% in 2024, then crashed by -104bps to 0.0% in 2025, then tumbled by -41bps to 0.0% in 2026.
  • The last three reported values for Return on Sales were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.